AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
48.24
-2.02 (-4.02%)
Oct 1, 2026, 3:07 PM EDT - Market open
AnaptysBio Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 1,442 | 1,999 | 1,342 | 403 | 569 | 881 | |
Market Cap Growth | 121.36% | 48.89% | 233.19% | -29.23% | -35.39% | -8.28% |
Enterprise Value | 1,548 | 1,989 | 1,440 | 340 | 486 | 760 |
Last Close Price | 50.26 | 67.50 | 32.32 | 8.83 | 14.28 | 20.66 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
PE Ratio | 6.90 | 7.63 | - | - | - | - |
Forward PE | 13.58 | 37.90 | 14.68 | 14.68 | 14.68 | 14.68 |
PS Ratio | 13.67 | 18.84 | 5.72 | 4.41 | 33.18 | 85.65 |
PB Ratio | 141.15 | 188.81 | 36.08 | 5.69 | 6.46 | 3.36 |
P/TBV Ratio | 136.98 | 188.81 | 36.08 | 5.69 | 6.46 | 3.36 |
P/FCF Ratio | - | - | 68.15 | - | - | - |
P/OCF Ratio | - | - | 68.15 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
EV/Sales Ratio | 14.66 | 18.75 | 6.14 | 3.72 | 28.31 | 73.84 |
EV/EBITDA Ratio | 23.67 | 30.28 | 6.35 | 5.14 | - | - |
EV/EBIT Ratio | 23.68 | 30.28 | 6.35 | 5.14 | - | - |
EV/FCF Ratio | - | - | 73.10 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Debt / Equity Ratio | 25.47 | 25.47 | 7.81 | 5.21 | 3.73 | 1.24 |
Debt / EBITDA Ratio | 4.10 | 4.10 | 1.27 | 5.38 | - | - |
Debt / FCF Ratio | - | - | 14.76 | - | - | - |
Net Debt / Equity Ratio | 9.96 | 9.96 | 2.12 | 1.19 | -0.71 | -0.45 |
Net Debt / EBITDA Ratio | 1.61 | 1.61 | 0.35 | 1.27 | 0.40 | 1.02 |
Net Debt / FCF Ratio | -1.00 | -1.00 | 4.01 | -0.62 | 0.51 | 1.59 |
Asset Turnover | - | - | 0.55 | 0.20 | 0.03 | 0.02 |
Quick Ratio | 5.54 | 5.54 | 6.36 | 7.18 | 10.62 | 16.99 |
Current Ratio | 5.61 | 5.61 | 9.07 | 9.51 | 10.87 | 17.17 |
Return on Equity (ROE) | - | - | 298.86% | 38.98% | -93.44% | -41.62% |
Return on Assets (ROA) | - | - | 33.44% | 8.83% | -18.47% | -11.48% |
Return on Invested Capital (ROIC) | 109.79% | 56.57% | 166.55% | 72.81% | -184.20% | -102.31% |
Return on Capital Employed (ROCE) | 23.30% | 23.30% | 69.70% | 15.10% | -37.90% | -19.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 1, 2026 | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Earnings Yield | 18.07% | 13.11% | -0.99% | -36.05% | -28.74% | -14.61% |
FCF Yield | -7.25% | -5.26% | 1.47% | -33.59% | -21.36% | -8.39% |
Buyback Yield / Dilution | -26.17% | -23.96% | -2.33% | -9.73% | 4.41% | -2.68% |